These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20233178)

  • 1. Effects of nicotine on cytochrome P450 2A6 and 2E1 activities.
    Hukkanen J; Jacob Iii P; Peng M; Dempsey D; Benowitz NL
    Br J Clin Pharmacol; 2010 Feb; 69(2):152-9. PubMed ID: 20233178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
    Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
    Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
    Sellers EM; Kaplan HL; Tyndale RF
    Clin Pharmacol Ther; 2000 Jul; 68(1):35-43. PubMed ID: 10945314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism.
    Benowitz NL; Peng M; Jacob P
    Clin Pharmacol Ther; 2003 Nov; 74(5):468-74. PubMed ID: 14586387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
    Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
    Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African Green monkeys: induction by chronic nicotine treatment.
    Lee AM; Yue J; Tyndale RF
    Drug Metab Dispos; 2006 Sep; 34(9):1508-15. PubMed ID: 16763012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans.
    Nakajima M; Yamagishi S; Yamamoto H; Yamamoto T; Kuroiwa Y; Yokoi T
    Clin Pharmacol Ther; 2000 Jan; 67(1):57-69. PubMed ID: 10668854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
    Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver.
    Howard LA; Micu AL; Sellers EM; Tyndale RF
    J Pharmacol Exp Ther; 2001 Nov; 299(2):542-50. PubMed ID: 11602665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
    Dempsey D; Tutka P; Jacob P; Allen F; Schoedel K; Tyndale RF; Benowitz NL
    Clin Pharmacol Ther; 2004 Jul; 76(1):64-72. PubMed ID: 15229465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.
    Hukkanen J; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2006 Nov; 80(5):522-30. PubMed ID: 17112808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
    Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
    Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
    Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats.
    Shaik IH; Mehvar R
    J Pharm Sci; 2011 Dec; 100(12):5281-92. PubMed ID: 21780121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
    Eap CB; Schnyder C; Besson J; Savary L; Buclin T
    Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine.
    Hukkanen J; Gourlay SG; Kenkare S; Benowitz NL
    Clin Pharmacol Ther; 2005 Mar; 77(3):159-69. PubMed ID: 15735610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application.
    Levi M; Dempsey DA; Benowitz NL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):23-34. PubMed ID: 17206525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
    Chen L; Yang CS
    Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.
    Murphy SE
    Chem Res Toxicol; 2017 Jan; 30(1):410-419. PubMed ID: 28092945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine 5'-oxidation and methyl oxidation by P450 2A enzymes.
    Murphy SE; Raulinaitis V; Brown KM
    Drug Metab Dispos; 2005 Aug; 33(8):1166-73. PubMed ID: 15860657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.